Canagliflozin Alters Mitochondrial Dynamics in Diabetic Kidn
2026-06-24
This study demonstrates that canagliflozin, a SGLT2 inhibitor, induces significant structural and functional improvements in proximal tubular cell mitochondria in hypertensive–diabetic mouse models. The findings highlight the mitochondrial remodeling as a potential mechanism underlying the kidney-protective effects of SGLT2 inhibition, with sex-specific responses noted.
EZ Cap Cy5 Firefly Luciferase mRNA: Workflow & Imaging Advan
2026-06-23
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) from APExBIO merges high-efficiency translation with dual-mode imaging for real-time monitoring of mRNA delivery and expression. Its Cy5 fluorescence and robust luciferase bioluminescence enable streamlined optimization, troubleshooting, and innovation in mRNA delivery workflows.
PPARγ Activation Regulates Macrophage Polarization in IBD Mo
2026-06-23
The referenced study demonstrates that activating PPARγ modulates macrophage polarization through the STAT-1/STAT-6 pathway, thereby attenuating inflammation and tissue damage in dextran sulfate sodium (DSS)-induced inflammatory bowel disease. These findings provide mechanistic insight into immune modulation strategies for IBD and inform the rational use of PPARγ agonists in preclinical research.
Sodium Citrate in 3D SERS Nanocluster Fabrication: Strategy
2026-06-22
Explore the pivotal mechanistic and strategic roles of sodium citrate in the fabrication of highly ordered 3D SERS nanocluster arrays. This article analyzes its function as a metal ion chelator, buffering agent, and protein stabilization reagent within emerging Polymer Pen Lithography workflows, providing protocol guidance and translational perspectives for researchers moving from bench to applied detection platforms.
Dasatinib Monohydrate: Applied Protocols in CML Research
2026-06-22
Dasatinib Monohydrate (BMS-354825) continues to redefine the boundaries of chronic myeloid leukemia research with its nanomolar kinase inhibition and versatility against imatinib-resistant BCR-ABL. This guide delivers actionable workflows, advanced troubleshooting, and evidence-backed protocol enhancements to maximize experimental reproducibility and translational impact.
Laminin (925-933): Advancing ECM Scaffold Science and Assays
2026-06-21
Explore the scientific and translational potential of Laminin (925-933), a defined Laminin B1 chain peptide, in advanced extracellular matrix (ECM) scaffold engineering and functional cell assays. This article uniquely bridges peptide-driven cell adhesion with next-generation organoid and islet research.
CNQX as a Precision Tool for Dissecting Glutamatergic Circui
2026-06-20
Discover how CNQX enables targeted investigation of glutamatergic neurotransmission and neural circuit dynamics. This article uniquely explores the practical implications of CNQX as a glutamatergic neurotransmission inhibitor in advanced neuroscience research.
FAST Enables Food-Grade, Surfactant-Free Nutraceutical Nanop
2026-06-19
This study introduces Facilitated Self-Assembling Technology (FAST) as a clean-label, surfactant-free method for preparing bioavailable nutraceutical nanoparticles using only food-grade components. The work demonstrates improved nanoparticle stability and biocompatibility, supporting scalable, regulatory-compliant delivery systems for functional supplements.
AG-221 (Enasidenib) and CD44: Rewiring AML Metabolism for Tr
2026-06-19
This article bridges mechanistic insight and translational strategy for researchers targeting IDH2-mutant acute myeloid leukemia. Highlighting AG-221 (Enasidenib) and CD44-mediated metabolic rewiring, it provides actionable guidance, protocol parameters, and a future-oriented outlook beyond conventional product literature.
AR and ARv7 in TNBC: Prognostic Role and Impact of N-Termina
2026-06-18
This study reveals that androgen receptor (AR) and its splice variant ARv7 are associated with poorer prognosis and increased metastasis in triple-negative breast cancer (TNBC) patients. Targeting AR/ARv7, specifically with the N-terminal domain inhibitor EPI-001, significantly abates metastatic markers and EMT regulators in TNBC models, highlighting new avenues for targeted intervention.
Bestatin (Ubenimex) in Aminopeptidase Assays: Applied Protoc
2026-06-18
Bestatin (Ubenimex) brings unparalleled specificity and reproducibility to aminopeptidase activity measurements and multidrug resistance research. Its selective inhibition profile and chemical-genetic utility empower researchers to dissect complex signaling pathways and optimize both plant and mammalian workflows.
Y-27632 in Advanced Organoid Models: Unveiling New Frontiers
2026-06-17
Explore how Y-27632, a selective ROCK inhibitor, is revolutionizing cytoskeletal dynamics modulation in next-generation organoid models. This article uniquely connects molecular mechanism, experimental rigor, and translational insight for cancer biology research.
Annexin V-PE Apoptosis Detection Kit: Mechanistic Precision
2026-06-17
Explore the Annexin V-PE Apoptosis Detection Kit for advanced apoptosis detection in live cells. This article uniquely bridges molecular pathway insights with assay optimization, empowering oncology researchers to refine experimental strategies.
3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Advanced Mechan
2026-06-16
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) enables innovative, pathway-specific modulation of cellular signaling. This article delivers advanced mechanistic analysis and practical guidance for using N2703 in biomedical research, distinguishing it from previous content.
4-Hydroxytamoxifen: Technical Use and Protocol Best Practice
2026-06-16
4-Hydroxytamoxifen is a high-purity estrogen receptor modulator used for DMSO-based protocols in breast and prostate cancer research and cardiac myocyte calcium handling studies. It should not be applied in workflows requiring aqueous or ethanol solubility, and improper storage or preparation can compromise experimental reproducibility.
458 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page